/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of cutting-edge life science tools, today announced an Early Access Program for its...
Bio-Techne is a Minnesota-based life science firm that manufactures products such as antibodies and bioactive reagents for the research and clinical diagnostic applications.